Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1797, Issue 6-7, 2010, Pages 1251-1259

  Gulbins, Erich ^a,d   Sassi, Nicola ^b   Grassmè, Heike ^a   Zoratti, Mario ^b   Szabò, Ildikò ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b CNR   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Department of Molecular Biology ^*  (Germany)

Author keywords

Apoptosis; Mitochondria; Potassium channel

Indexed keywords

CYTOCHROME C; POTASSIUM CHANNEL KV1.3; PROTEIN BAX; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL STRAIN MCF 7; CELL TYPE; CHANNEL GATING; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN CELL; HYPERPOLARIZATION; LYMPHOCYTE; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BINDING, COMPETITIVE; CELL LINE, TUMOR; CYTOCHROMES C; HUMANS; KV1.3 POTASSIUM CHANNEL; LYMPHOCYTES; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; RECOMBINANT FUSION PROTEINS; SCORPION VENOMS; SIGNAL TRANSDUCTION;

EID: 77953758600     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2010.01.018     Document Type: Article

References (60)

1. + channels. EMBO J. 1999, 18:5540-5547.
2. Lang F., Föller M., Lang K.S., Lang P.A., Ritter M., Gulbins E., Vereninov A., Huber S.M. Ion channels in cell proliferation and apoptotic cell death. J. Membr. Biol. 2005, 205:147-157.
3. Stühmer W., Alves F., Hartung F., Zientkowska M., Pardo L.A. Potassium channels as tumour markers. FEBS Lett. 2006, 580:2850-2852.
4. Kunzelmann K. Ion channels and cancer. J. Membr. Biol. 2005, 205:159-173.
5. Nilius B. Chloride channels go cell cycling. J. Physiol. 2001, 532:581.
6. Nagy P., Panyi G., Jenei A., Bene L., Jr R., Gáspár J.Matkó, Damjanovich S. Ion channel activities regulate transmembrane signaling in thymocyte apoptosis and T-cell activation. Immunol. Lett. 1995, 44:91-95.
7. + channel in T lymphocytes upon Fas stimulation. J. Biol. Chem. 1996, 271:20465-20469.
8. Yu S.P., Yeh C.H., Sensi S.L., Gwag B.J., Canzoniero L.M., Farhangrazi Z.S., Ying H.S., Tian M., Dugan L.L., Choi D.W. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 1997, 278:114-117.
9. Khan A.A., Soloski M.J., Sharp A.H., Schilling G., Sabatini D.M., Li S.H., Ross C.A., Snyder S.H. Lymphocyte apoptosis: mediation by increased type 3 inositol 1, 4, 5-trisphosphate receptor. Science 1996, 273:503-507.
10. Chvatchko Y., Valera S., Aubry J.P., Renno T., Buell G., Bonnefoy J.Y. The involvement of an ATP-gated ion channel, P(2X1), in thymocyte apoptosis. Immunity 1996, 5:275-283.
11. Szabò I., Lepple-Wienhues A., Kaba K.N., Zoratti M., Gulbins E., Lang F. Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6169-6174.
12. Maeno E., Ishizaki Y., Kanaseki T., Hazama A., Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9487-9492.
13. Lepple-Wienhues A., Belka C., Laun T., Jekle A., Walter B., Wieland U., Welz M., Heil L., Kun J., Busch G., Weller M., Bamberg M., Gulbins E., Lang F. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13795-13800.
14. Arcangeli A., Crociani O., Lastraioli E., Masi A., Pillozzi S., Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 2009, 16:66-93.
15. Jonas E.A. Molecular participants in mitochondrial cell death channel formation during neuronal ischemia. Exp. Neurol. 2009, 218:203-212.
16. Shoshan-Barmatz V., Israelson A., Brdiczka D., Sheu S.S. The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. Curr. Pharm. Des. 2006, 12:2249-2270.
17. + channels and their role in cardioprotection. Circ. Res. 2004, 94:420-432.
18. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 1999, 79:1127-1155.
19. + cycle. Biochim. Biophys. Acta 2003, 1606:23-41.
20. Czyz A., Szewczyk A., Nalecz M.J., Wojtczak L. The role of mitochondrial potassium fluxes in controlling the protonmotive force in energized mitochondria. Biochem. Biophys. Res. Commun. 1995, 210:98-104.
21. Pathania D., Millard M., Ne'amati N. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv. Drug Deliv. Rev. 2009, 61:1250-1275.
22. Garlid K.D., Paucek P., Yarov-Yarovoy V., Sun X., Schindler P.A. The mitochondrial KATP channel as a receptor for potassium channel openers. J. Biol. Chem. 1996, 271:8796-8799.
23. Lee Y.S., Sayeed M.M., Wurster R.D. In vitro antitumor activity of cromakalim in human brain tumor cells. Pharmacology 1994, 49:69-74.
24. Holmuhamedov E., Lewis L., Bienengraeber M., Holmuhamedova M., Jahangir A., Terzic A. Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J. 2002, 16:1010-1016.
25. Abdul M., Santo A., Hoosein N. Activity of potassium channel-blockers in breast cancer. Anticancer Res. 2003, 23:3347-3351.
26. Qian X., Li J., Ding J., Wang Z., Duan L., Hu G. Glibenclamide exerts an antitumor activity through reactive oxygen species-c-jun NH2-terminal kinase pathway in human gastric cancer cell line MGC-803. Biochem. Pharmacol. 2008, 76:1705-1715.
27. Bock J., Szabó I., Jekle A., Gulbins E. Actinomycin D-induced apoptosis involves the potassium channel Kv1.3. Biochem. Biophys. Res. Commun. 2002, 295:526-531.
28. Chandy K.G., DeCoursey T.E., Cahalan M.D., McLaughlin C., Gupta S. Voltage-gated potassium channels are required for human T lymphocyte activation. J. Exp. Med. 1984, 160:369-385.
29. + channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 2004, 25:280-289.
30. + channels in T lymphocytes: functional consequences for volume regulation. Proc. Natl Acad. Sci. USA 1993, 90:10036-10040.
31. Szabó I., Bock J., Grassmé H., Soddemann M., Wilker B., Lang F., Zoratti M., Gulbins E. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc. Natl Acad. Sci. USA 2008, 105:14861-14866.
32. Szabò I., Bock J., Jekle A., Soddemann M., Adams C., Lang F., Zoratti M., Gulbins E. A novel potassium channel in lymphocyte mitochondria. J. Biol. Chem. 2005, 280:12790-12798.
33. Zoratti M., De Marchi U., Gulbins E., Szabò I. Novel channels of the inner mitochondrial membrane. Biochim. Biophys. Acta, Bioenerg. 2009, 1787:351-363.
34. Arnold R., Brenner D., Becker M., Frey C.R., Krammer P.H. How T lymphocytes switch between life and death. Eur. J. Immunol. 2006, 36:1654-1658.
35. Tafani M., Karpinich N.O., Serroni A., Russo M.A., Farber J.L. Re-evaluation of the distinction between type I and type II cells: the necessary role of the mitochondria in both the extrinsic and intrinsic signaling pathways upon Fas receptor activation. J. Cell. Physiol. 2006, 208:556-565.
36. - synthesis. Immunology 1996, 89:205-212.
37. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244:6049-6055.
38. + channel (SKC1): oligomeric stoichiometry and stability. Biochemistry 1997, 36:10343-10352.
39. O'Rourke B., Cortassa S., Aon M.A. Mitochondrial ion channels: gatekeepers of life and death. Physiology 2005, 20:303-315.
40. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
41. Zoratti M., Szabò I. The mitochondrial permeability transition. Biochim. Biophys. Acta 1995, 1241:139-176.
42. Costantini P., Chernyak B.V., Petronilli V., Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 1996, 271:6746-6751.
43. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., Pelliccia G., Luzi L., Minucci S., Marcaccio M., Pinton P., Rizzuto R., Bernardi P., Paolucci F., Pelicci P.G. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
44. Joshi B., Li L., Taffe B.G., Zhu Z., Wahl S., Tian H., Ben-Josef E., Taylor J.D., Porter A.T., Tang D.G. Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain. Cancer Res. 1999, 59:4343-4355.
45. Quillet-Mary A., Jaffrézou J.P., Mansat V., Bordier C., Naval J., Laurent G. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J. Biol. Chem. 1997, 272:21388-21395.
46. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001, 495:12-15.
47. Zhou M., Diwu Z., Panchuk-Voloshina N., Haugland R.P. A stable nonfluorescent derivative of resorfin for the fluorimetric determination of hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal. Biochem. 1997, 253:162-168.
48. Iijima T., Mishima T., Akagawa K., Iwao Y. Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res. 2003, 993:140-145.
49. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997, 91:627-637.
50. Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab. Rev. 2007, 39:443-455.
51. Ott M., Zhivotovsky B., Orrenius S. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ. 2007, 14:1243-1247.
52. Uren R.T., Dewson G., Bonzon C., Lithgow T., Newmeyer D.D., Kluck R.M. Mitochondrial release of pro-apoptotic proteins: electrostatic interactions can hold cytochrome c but not Smac/DIABLO to mitochondrial membranes. J. Biol. Chem. 2005, 280:2266-2274.
53. Spencer R.H., Sokolov Y., Li H., Takenaka B., Milici A.J., Aiyar J., Nguyen A., Park H., Jap B.K., Hall J.E., Gutman G.A., Chandy K.G. Purification, visualization, and biophysical characterization of Kv1.3 tetramers. J. Biol. Chem. 1997, 272:2389-2395.
54. + channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 2004, 25:280-289.
55. + channel revealed by the NMR-derived structures of scorpion toxins. Neuron 1995, 15:1169-1181.
56. Gutman G.A., Chandy K.G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stühmer W., Wang X. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 2005, 57:473-508.
57. Brevet M., Haren N., Sevestre H., Merviel P., Ouadid-Ahidouch H. DNA methylation of K(v)1.3 potassium channel gene promoter is associated with poorly differentiated breast adenocarcinoma. Cell. Physiol. Biochem. 2009, 24:25-32.
58. Abdul M., Hoosein N. Reduced Kv 1.3 potassium channel expression in human prostate cancer. J. Membr. Biol. 2006, 214:99-102.
59. Bednarczyk P. Potassium channels in brain mitochondria. Acta Biochim. Pol. 2009, 56:385-392.
60. Annis M.G., Soucie E.L., Dlugosz P.J., Cruz-Aguado J.A., Penn L.Z., Leber B., Andrews D.W. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J. 2005, 24:2096-2103.